![Ramzi Amri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Ramzi Amri is currently Chief Financial Officer at Oncoinvent ASA starting in 2026.
Formerly, Dr. Amri was VP, Head-Development Strategy & Execution at Galapagos NV.
Education includes a doctorate from the University of Amsterdam.
Ramzi Amri active positions
| Companies | Position | Start |
|---|---|---|
| ONCOINVENT ASA | Director of Finance/CFO | 2026-01-14 |
Former positions of Ramzi Amri
| Companies | Position | End |
|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | Corporate Officer/Principal | - |
Training of Ramzi Amri
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Galapagos NV
 Galapagos NV BiotechnologyHealth Technology Manufactures and develops pharmaceutical products for oncology | Health Technology |
University of Amsterdam
 University of Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BerGenBio ASA
 BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
- Stock Market
- Insiders
- Ramzi Amri
